These results expand the role of HSP110 in sustaining HR DDR, in addition to what has been previously demonstrated in colon cancer cells in which this HSP is involved in NHEJ DNA repair, and thus, its inhibition is able to sensitize these cells to the cytotoxic effects of genotoxic therapies [20]. This evidence concerns the gene HSP90B2P and colonic neoplasm.